Leipzig Pharmacologists Research Molecules to Combat Prostate Cancer
Prostate cancer is the second most common tumour disease in men worldwide. A better understanding of molecular mechanisms is crucial in the development of new therapeutics. A research group led by pharmacologist Professor Achim Aigner at Leipzig University has now developed an experimental therapy…